| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 04/29/2004 | WO2004035769A1 Improved immunotherapy |
| 04/29/2004 | WO2004035756A2 MODIFIED NUCLEOTIDE SEQUENCE ENCODING C. ALBICANS KiF1 KINESIN PROTEIN |
| 04/29/2004 | WO2004035749A2 MODIFIED NUCLEOTIDE SEQUENCE ENCODING C. ALBICANS Kip3 KINESIN PROTEIN |
| 04/29/2004 | WO2004035745A2 Cloning of cytochrome p450 genes from nicotiana |
| 04/29/2004 | WO2004035743A2 Site specific incorporation of keto amino acids into proteins |
| 04/29/2004 | WO2004035733A2 Isolated human hepsin/46 proteins, nucleic acid molecules encoding human hepsin/46 proteins, and uses thereof |
| 04/29/2004 | WO2004035730A2 Crystals and structures of atp phosphoribosyltransferase |
| 04/29/2004 | WO2004035729A2 Esterases, nucleic acids encoding them and methods of making and using them |
| 04/29/2004 | WO2004035628A1 Regulation o-if the cre recombinase using a dissociation/re association system of said recombinase |
| 04/29/2004 | WO2004035617A2 Feedback-resistant homoserine transsuccinylases |
| 04/29/2004 | WO2004035611A2 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 04/29/2004 | WO2004035605A2 Glycoprotein synthesis |
| 04/29/2004 | WO2004035604A2 Spleen tyrosine kinase catalytic domain:crystal structure and binding pockets thereof |
| 04/29/2004 | WO2004035170A2 Composition for separating molecules |
| 04/29/2004 | WO2004035070A1 Induction of gene expression using a high concentration sugar mixture |
| 04/29/2004 | WO2004035010A2 Methods and organisms for production of b6 vitamers |
| 04/29/2004 | WO2004020619A9 Modified phospholipase c-gamma-2, expression products, and non-human animal models comprising said genes, and therapeutic uses |
| 04/29/2004 | WO2004012732A3 Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy |
| 04/29/2004 | WO2004011491A3 Peptidyl-trna hydrolase of enterococcus faecalis |
| 04/29/2004 | WO2004007706A8 Plant nucleotide-sugar pyrophosphatase/phosphodiesterase (nppase), method of obtaining same and use of same in the production of assay devices and in the production of transgenic plants |
| 04/29/2004 | WO2004003185A3 Plant deoxyribonucleoside kinase enzymes and their use |
| 04/29/2004 | WO2003106969A3 Ribonuclease zymogen design |
| 04/29/2004 | WO2003104408A3 Commercial production of recombinant manganese-dependent peroxidase in plants |
| 04/29/2004 | WO2003089622A3 Novel genes, compositions, and methods for modulating the unfolded protein response |
| 04/29/2004 | WO2003087341A3 Targeted chromosomal mutagenesis using zinc finger nucleases |
| 04/29/2004 | WO2003080796A9 Ordered biological nanostructures formed from chaperonin polypeptides |
| 04/29/2004 | WO2003074715A3 Process for the production of unsaturated fatty acids |
| 04/29/2004 | WO2003060127A3 Genes and proteins involved in the biosynthesis of lipopeptides |
| 04/29/2004 | WO2003053363A3 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor |
| 04/29/2004 | WO2003052374A8 Methods for identifying racemases |
| 04/29/2004 | WO2003038040A9 32235, a human aminotransferase family member and uses therefor |
| 04/29/2004 | WO2003025156A9 Methods and apparatuses for purification |
| 04/29/2004 | WO2003000715A8 Chimeric histone acetyltransferase polypeptides |
| 04/29/2004 | WO2002097082A8 Engineered biosynthesis of novel polyenes |
| 04/29/2004 | WO2002072630A3 Nucleic acid-associated proteins |
| 04/29/2004 | WO2002070721A8 Recombinant dimorphic fungal cell |
| 04/29/2004 | WO2002070669A3 Secreted proteins |
| 04/29/2004 | WO2002068599A3 Retinoid inducible proteins of vascular smooth muscle cells and uses thereof |
| 04/29/2004 | WO2002064759A8 Method of providing polypeptide preparations with reduced enzymatic side activities |
| 04/29/2004 | WO2002046372A9 Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites |
| 04/29/2004 | WO2002020804A8 Rat cathepsin, dipeptidyl peptidase i (dppi): crystal structure, inhibitors and its uses |
| 04/29/2004 | WO2002018341A8 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 04/29/2004 | WO1999028440A9 Nucleic acid encoding mammalian ubr1 |
| 04/29/2004 | WO1991000348A3 Modified vp1/p2a regions of the rhinoviral system |
| 04/29/2004 | US20040083503 Plants, seeds and oils having an elevated total monounsaturated fatty acid content |
| 04/29/2004 | US20040083500 Compositions and methods to stack multiple nucleotide sequences of interest in the genome of a plant |
| 04/29/2004 | US20040083496 Genetic engineered polypeptides; incubation, amplification |
| 04/29/2004 | US20040082770 Herbicide resistant, transgenic plants; genetic engineered polynucleotide |
| 04/29/2004 | US20040082758 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated |
| 04/29/2004 | US20040082659 Enhancement of vascular function by modulation of endogenous nitric oxide production or activity |
| 04/29/2004 | US20040082597 Use of CRF antagonists and related compositions |
| 04/29/2004 | US20040082535 Glucocerebrosidas DNA molecule having modification in one nucleotide that disrupts splicing consensus sequence and prevents splicing of mRNA produced from DNA molecule, while preserving ability of DNA to express glucocerebrosidas enzyme |
| 04/29/2004 | US20040082518 Antiinflammatory/coagulant prodrug |
| 04/29/2004 | US20040082515 Regulation of biological events using novel compounds |
| 04/29/2004 | US20040082068 Insertion of lyases enzyme into Rna; polymerase chain reactions; amplification; viricides |
| 04/29/2004 | US20040082061 Drug metabolizing enzymes |
| 04/29/2004 | US20040082053 Thermostable glutaminase and thermostable glutaminase gene |
| 04/29/2004 | US20040082052 Crystal structure |
| 04/29/2004 | US20040082051 Anticancert agents; polypeptides; controlling matrix degradation |
| 04/29/2004 | US20040082050 Chorismate biosynthesis enzymes |
| 04/29/2004 | US20040082049 Method of screening compounds that inhibit lysophosphatidic acid acyltransferase |
| 04/29/2004 | US20040082048 Mixture containing enzyme; malaria therapy |
| 04/29/2004 | US20040082046 Coated enzyme-containing catalyst |
| 04/29/2004 | US20040082030 Angiogenesis factor diseases; antiproliferative agents |
| 04/29/2004 | US20040082028 Genetic engineering; three-dimensional construction; heat resistance; used for converting starch to sugar |
| 04/29/2004 | US20040082027 Conjugate of a tissue non-specific alkaline phosphatase and dextran, process for its production and use thereof |
| 04/29/2004 | US20040082025 Modified yeasts and uses thereof, in particular for producing steroid derivatives |
| 04/29/2004 | US20040082017 Protein for drug screening; purification of lysosomes; fusion protein; nucleotide sequence coding polypeptide; quantitative analysis |
| 04/29/2004 | US20040082007 Genetic engineering of isolated nucleic acids; pain therapy; central nervous system disorders; inserting plasmids; hybridization |
| 04/29/2004 | US20040081999 Genetic engineered protein; controlling cell proliferation, cell differentiation |
| 04/29/2004 | US20040081998 Novel carboxylesterase nucleic acid molecules, proteins and uses thereof |
| 04/29/2004 | US20040081995 Dna polymerase; genetic engineering |
| 04/29/2004 | US20040081992 Controlling gene expression; cell differentiation; drug screening; complexing, measuring binding |
| 04/29/2004 | US20040081989 Infantile neurodegradation disorders; behaviot disorders; anticonvulsants; brain disorders |
| 04/29/2004 | US20040081983 Kinases and phosphatases |
| 04/29/2004 | US20040081980 Polynucleotides; genetic engineering; diagnosis, therapy, prevent disease; detect binding to antibody |
| 04/29/2004 | US20040081965 Mutants; genetic engineering; amplification |
| 04/29/2004 | US20040081963 Joining polymerase to nucleic acids |
| 04/29/2004 | US20040081961 Genetic engineering; therapy, diagnosis of disease; gastrointestinal, cardiovascular diseases; autoimmune disease; antiinflammatory agents; central nervous system disorders; antitumor, anticancer agents |
| 04/29/2004 | US20040081651 Crystal structure of the complex between one such antibody and the alpha 1-I domain of VLA-1, and to the use of this structural information for computational drug design |
| 04/29/2004 | US20040081648 Adzymes and uses thereof |
| 04/29/2004 | US20040081647 For inhibiting receptor-mediated signaling activity of an extracellular substrate polypeptide |
| 04/29/2004 | US20040081646 Group B Streptococcal phage lysin |
| 04/29/2004 | US20040081645 Glycogen storage disease type II treatment comprising human acid glucosidase, mannitol and sucrose in aqueous solution |
| 04/29/2004 | US20040081644 Amino acid sequences of human phosphatase peptides and proteins that are related to the protein tyrosine phosphatase subfamily |
| 04/29/2004 | DE10328887A1 Alkalische Protease Alkaline protease |
| 04/29/2004 | DE10294485T5 Mit Mnk-Kinase homologe Proteine, die in die Regulation der Energiehomöostase und den Organellenmetabolismus involviert sind Mnk homologous proteins with kinase, that are involved in the regulation of energy homeostasis and the metabolism organelle |
| 04/29/2004 | DE10247437A1 Feedback-resistente Homoserin-Transsuccinylasen Feedback-resistant homoserine transsuccinylases |
| 04/29/2004 | CA2503307A1 Soluble rna polymerase protein and methods for the use thereof |
| 04/29/2004 | CA2502539A1 Protein modification |
| 04/29/2004 | CA2502434A1 Plant alpha farnesene synthase and polynucleotides encoding same |
| 04/29/2004 | CA2502257A1 A method of modulating endothelial cell activity by modulating the functional levels level of sphingosine kinase |
| 04/29/2004 | CA2502201A1 Protein synthesis system using xenopus oocyte extract |
| 04/29/2004 | CA2502029A1 Site specific incorporation of keto amino acids into proteins |
| 04/29/2004 | CA2501631A1 Cloning of cytochrome p450 genes from nicotiana |
| 04/29/2004 | CA2500653A1 Glycoprotein synthesis |
| 04/29/2004 | CA2500336A1 Improved immunotherapy |
| 04/29/2004 | CA2498345A1 Methods for separating molecules |
| 04/29/2004 | CA2498341A1 Composition for separating molecules |
| 04/29/2004 | CA2498213A1 Induction of gene expression using a high concentration sugar mixture |